LyondellBasell Industries N.V. operates as a chemical company in the United States, Germany, Mexico, Italy, Poland, France, Japan, China, the Netherlands, and internationally. The company operates in six segments: Olefins and PolyolefinsAmericas; Olefins and PolyolefinsEurope, Asia, International; Intermediates and Derivatives; Advanced Polymer Solutions; Refining; and Technology. It produces and markets olefins and co-products, such as ethylene, aromatics, propylene and butadiene; polyolefins; polyethylene; and polypropylene homopolymers and copolymers; and propylene oxide and derivatives; oxyfuels and related products; and intermediate chemicals, such as styrene monomer, acetyls, and ethylene oxide. The company also produces and markets compounding and solutions, including polypropylene compounds, engineered plastics, masterbatches, engineered composites, colors and powders, and advanced polymers, such as catalloy and polybutene-1; and refines heavy, high-sulfur crude oil and other crude oils, as well as refined products, including gasoline and distillates. In addition, it develops and licenses chemical and polyolefin process technologies; manufactures and sells polyolefin catalysts; and serves food packaging, home furnishings, automotive components, and paints and coatings applications. LyondellBasell Industries N.V. was incorporated in 2009 and is headquartered in Houston, Texas.

LyondellBasell Industries NV Class A (Netherlands)

Tate & Lyle ( ($GB:TATE) ) just unveiled an announcement. Tate & Lyle PLC, the UK-based ingredients and food solutions group, has published its 202...

Tate & Lyle Publishes 2026 Annual Report and Sets July AGM

An update from Tate & Lyle ( ($GB:TATE) ) is now available. Tate & Lyle has disclosed a change in the shareholding of its chief executive, Nick Ham...

Tate & Lyle CEO Receives Shares After Performance Award Vests

Rallybio ( ($RLYB) ) just unveiled an announcement. On May 31, 2026, Rallybio agreed to acquire Avenzo Therapeutics in an all-stock merger that wil...

Rallybio to Merge with Avenzo, Shifting to Oncology

LyondellBasell ( ($LYB) ) just unveiled an update. On May 29, 2026, LyondellBasell subsidiaries executed an Eighth Amendment to their structured ac...

LyondellBasell Amends and Extends Receivables Financing Facility

Berenberg Bank analyst reiterated a Hold rating on Tate & Lyle today and set a price target of p554.00. In a report released yesterday, Barclays al...

Berenberg Bank Reaffirms Their Hold Rating on Tate & Lyle (TATE)

In a report released today, Alex Sloane from Barclays maintained a Hold rating on Tate & Lyle, with a price target of £5.25. According to TipRanks,...

Barclays Remains a Hold on Tate & Lyle (TATE)

Kepler Capital analyst Karel Zoete maintained a Hold rating on Tate & Lyle on May 22 and set a price target of p547.00. The company’s shares closed...

Kepler Capital  Sticks to Its Hold Rating for Tate & Lyle (TATE)

LyondellBasell ( ($LYB) ) just unveiled an update. At its recent Annual Meeting, LyondellBasell shareholders, representing about 88% of eligible sh...

Current Quarter	$2.85	Next Quarter	$3.36
Current Year	$8.73	Next Year	$7.2
QoQ Growth	+17.9%	YoY Growth	-17.5%
3Y EPS CAGR	-100.0%	Target Price	$80.00
Consensus	Buy	Upside	+33.2%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	LYB	$60.07	-2.82%	9.69M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	LYB	$60.07	-2.8%	9.69M
3
4
5
6

LYB

LYB

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get LyondellBasell Industries NV Class A (Netherlands) Data in Excel

Get LyondellBasell Industries NV Class A (Netherlands) Data in Excel